Heron Therapeutics Inc (HRTX)
2.795
+0.20
(+7.92%)
USD |
NASDAQ |
Apr 23, 16:00
2.795
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics Enterprise Value: 482.70M for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 482.70M |
| April 19, 2024 | 490.21M |
| April 18, 2024 | 500.73M |
| April 17, 2024 | 509.75M |
| April 16, 2024 | 533.81M |
| April 15, 2024 | 536.81M |
| April 12, 2024 | 530.80M |
| April 11, 2024 | 535.31M |
| April 10, 2024 | 503.74M |
| April 09, 2024 | 514.26M |
| April 08, 2024 | 506.75M |
| April 05, 2024 | 506.75M |
| April 04, 2024 | 479.69M |
| April 03, 2024 | 479.69M |
| April 02, 2024 | 476.68M |
| April 01, 2024 | 500.73M |
| March 28, 2024 | 509.75M |
| March 27, 2024 | 505.24M |
| March 26, 2024 | 505.24M |
| March 25, 2024 | 536.81M |
| March 22, 2024 | 539.82M |
| March 21, 2024 | 551.85M |
| March 20, 2024 | 551.85M |
| March 19, 2024 | 536.81M |
| March 18, 2024 | 538.32M |
| Date | Value |
|---|---|
| March 15, 2024 | 553.35M |
| March 14, 2024 | 551.85M |
| March 13, 2024 | 545.83M |
| March 12, 2024 | 448.12M |
| March 11, 2024 | 455.64M |
| March 08, 2024 | 484.20M |
| March 07, 2024 | 482.70M |
| March 06, 2024 | 466.16M |
| March 05, 2024 | 478.19M |
| March 04, 2024 | 477.43M |
| March 01, 2024 | 485.70M |
| February 29, 2024 | 493.22M |
| February 28, 2024 | 499.23M |
| February 27, 2024 | 505.12M |
| February 26, 2024 | 484.08M |
| February 23, 2024 | 484.08M |
| February 22, 2024 | 487.09M |
| February 21, 2024 | 506.63M |
| February 20, 2024 | 524.66M |
| February 16, 2024 | 524.66M |
| February 15, 2024 | 526.16M |
| February 14, 2024 | 502.12M |
| February 13, 2024 | 470.56M |
| February 12, 2024 | 488.59M |
| February 09, 2024 | 458.54M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
177.09M
Minimum
Nov 14 2023
2.145B
Maximum
Dec 03 2019
880.27M
Average
947.89M
Median
Enterprise Value Benchmarks
| United Therapeutics Corp | 8.725B |
| Esperion Therapeutics Inc | 531.87M |
| Aldeyra Therapeutics Inc | 103.78M |
| Ocular Therapeutix Inc | 633.40M |
| Clearside Biomedical Inc | 76.87M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.72M |
| Revenue (Quarterly) | 34.23M |
| Total Expenses (Quarterly) | 44.45M |
| EPS Diluted (Quarterly) | -0.05 |
| Gross Profit Margin (Quarterly) | 71.12% |
| Profit Margin (Quarterly) | -31.33% |
| Earnings Yield | -30.05% |
| Normalized Earnings Yield | -30.05 |